Compared to minimally invasive surgery, endoscopic submucosal dissection (ESD) represents an advanced, less-invasive endoscopic treatment for early gastrointestinal cancer. ESD has significant ...

For patients with large benign colonic lesions, endoscopic submucosal dissection (ESD) is associated with reduced recurrence at six months compared with endoscopic mucosal resection (EMR), according ...

Endoscopic submucosal dissection or ESD is an advanced endoscopic procedure that allows for the complete removal of early tumors and cancers of the esophagus, stomach and rectum. In 2015, trained ...

FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) ...

Background Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal cancers and provides specimens suitable for precise pathological risk assessment. However, ...

Insights from a 21-year analysis of mortality due to hypertension and esophageal cancer in the United States. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) ...

Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and ...